However, cytopathological and mutational analyses of the pericardial fluid confirmed the diagnosis of ROS1-rearranged lung adenocarcinoma, and an adequate therapeutic effect was obtained by oral administration of entrectinib. Here, ROS1 is linked to lung adenocarcinoma.